References

1. Mauvais-Jarvis F, Sobngwi E, Porcher R, Riveline JP, Kevorkian JP, Vaisse C et al. Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. 2004 Mar; 53(3): 645-53. PubMed | Google Scholar


2. Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications: a systematic review. BMC public health. 2011 Jul 14; 11: 564. PubMed | Google Scholar


3. Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab. 2007 Jan; 3(1): 36-45. PubMed | Google Scholar


4. Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes. 2008 Apr; 57(4): 1084-92. PubMed | Google Scholar


5. Sobngwi E, Gautier JF, Kevorkian JP, Villette JM, Riveline JP, Zhang S et al. High prevalence of glucose-6-phosphate dehydrogenase deficiency without gene mutation suggests a novel genetic mechanism predisposing to ketosis-prone diabetes. The Journal of clinical endocrinology and metabolism. 2005 Aug; 90(8): 4446-51. PubMed | Google Scholar


6. Sobngwi E, Choukem SP, Agbalika F, Blondeau B, Fetita LS, Lebbe C et al. Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-saharan africans. JAMA. 2008 Jun 18; 299(23): 2770-6. PubMed | Google Scholar